MedTrace Logo

Comparison of Contoura Vision Outcomes Programmed Using the Manifest Refraction Verses Using Phorcides Planning Software in Patients With Oblique Astigmatism

NCT05888337 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2023-12-13

No results posted yet for this study

Summary

The objective is to compare the percentage of monocular UDVA -0.1 logMAR (20/16) outcomes for each planning strategy (Phorcides and manifest refraction) at the 3-month post operative visit.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

Contoura LASIK with Phorcides planning strategy

Bilateral treatment with topography guided LASIK

DEVICE

Contoura LASIK with manifest refraction planning strategy

Bilateral treatment with topography guided LASIK

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Bismarck Lasik

    lead OTHER

Principal Investigators

  • Stephen A Wexler, MD · Bismarck Lasik

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2023-12-05
Completion
2023-12-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888337 on ClinicalTrials.gov